Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage

Se Yeong Oh, Young Woo Sohn, Jong Whi Park, Hyo Jung Park, Hye Min Jeon, Tae Kyung Kim, Joong Seob Lee, Ji Eun Jung, Xun Jin, Yong Gu Chung, Young Ki Choi, Seungkwon You, Jang Bo Lee, Hyunggee Kim

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We have established several glioma-relevant oncogene-engineered cancer cells to reevaluate the oncogene-selective cytotoxicity of previously well-characterized anticancer drugs, such as etoposide, doxorubicin, staurosporine, and carmustine. Among several glioma-relevant oncogenes (activated epidermal growth factor receptor, Ras, and Akt, as well as Bcl-2 and p53DD used in the present study), the activated epidermal growth factor receptor, Ras, and Akt exerted oncogenic transformation of Ink4a/Arf -/- murine astrocyte cells. We identified that etoposide, a topoisomerase II inhibitor, caused selective killing of myristylated Akt (Akt-myr)-transduced Ink4a/Arf-/- astrocytes and U87MG cells in a dose- and time-dependent manner. Etoposide-selective cytotoxicity in the Akt-myr-transduced cells was shown to be caused by nonapoptotic cell death and occurred in a p53-independent manner. Etoposide caused severe reactive oxygen species (ROS) accumulation preferentially in the Akt-myr-transduced cells, and elevated ROS rendered these cells highly sensitive to cell death. The etoposide-selective cell death of Akt-myr-transduced cells was attenuated by pepstatin A, a lysosomal protease inhibitor. In the present study, we show that etoposide might possess a novel therapeutic activity for oncogenic Akt-transduced cancer cells to kill preferentially through ROS-mediated damage.

Original languageEnglish
Pages (from-to)2178-2187
Number of pages10
JournalMolecular Cancer Therapeutics
Volume6
Issue number8
DOIs
Publication statusPublished - 2007 Aug 1

Fingerprint

Etoposide
Brain Neoplasms
Reactive Oxygen Species
Cell Death
Oncogenes
Epidermal Growth Factor Receptor
Glioma
Astrocytes
Topoisomerase II Inhibitors
Carmustine
Staurosporine
Protease Inhibitors
Doxorubicin
Neoplasms
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Drug Discovery
  • Pharmacology

Cite this

Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage. / Oh, Se Yeong; Sohn, Young Woo; Park, Jong Whi; Park, Hyo Jung; Jeon, Hye Min; Kim, Tae Kyung; Lee, Joong Seob; Jung, Ji Eun; Jin, Xun; Chung, Yong Gu; Choi, Young Ki; You, Seungkwon; Lee, Jang Bo; Kim, Hyunggee.

In: Molecular Cancer Therapeutics, Vol. 6, No. 8, 01.08.2007, p. 2178-2187.

Research output: Contribution to journalArticle

Oh, Se Yeong ; Sohn, Young Woo ; Park, Jong Whi ; Park, Hyo Jung ; Jeon, Hye Min ; Kim, Tae Kyung ; Lee, Joong Seob ; Jung, Ji Eun ; Jin, Xun ; Chung, Yong Gu ; Choi, Young Ki ; You, Seungkwon ; Lee, Jang Bo ; Kim, Hyunggee. / Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage. In: Molecular Cancer Therapeutics. 2007 ; Vol. 6, No. 8. pp. 2178-2187.
@article{b7d765e5e4154319828aed1de9fec706,
title = "Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage",
abstract = "We have established several glioma-relevant oncogene-engineered cancer cells to reevaluate the oncogene-selective cytotoxicity of previously well-characterized anticancer drugs, such as etoposide, doxorubicin, staurosporine, and carmustine. Among several glioma-relevant oncogenes (activated epidermal growth factor receptor, Ras, and Akt, as well as Bcl-2 and p53DD used in the present study), the activated epidermal growth factor receptor, Ras, and Akt exerted oncogenic transformation of Ink4a/Arf -/- murine astrocyte cells. We identified that etoposide, a topoisomerase II inhibitor, caused selective killing of myristylated Akt (Akt-myr)-transduced Ink4a/Arf-/- astrocytes and U87MG cells in a dose- and time-dependent manner. Etoposide-selective cytotoxicity in the Akt-myr-transduced cells was shown to be caused by nonapoptotic cell death and occurred in a p53-independent manner. Etoposide caused severe reactive oxygen species (ROS) accumulation preferentially in the Akt-myr-transduced cells, and elevated ROS rendered these cells highly sensitive to cell death. The etoposide-selective cell death of Akt-myr-transduced cells was attenuated by pepstatin A, a lysosomal protease inhibitor. In the present study, we show that etoposide might possess a novel therapeutic activity for oncogenic Akt-transduced cancer cells to kill preferentially through ROS-mediated damage.",
author = "Oh, {Se Yeong} and Sohn, {Young Woo} and Park, {Jong Whi} and Park, {Hyo Jung} and Jeon, {Hye Min} and Kim, {Tae Kyung} and Lee, {Joong Seob} and Jung, {Ji Eun} and Xun Jin and Chung, {Yong Gu} and Choi, {Young Ki} and Seungkwon You and Lee, {Jang Bo} and Hyunggee Kim",
year = "2007",
month = "8",
day = "1",
doi = "10.1158/1535-7163.MCT-07-0111",
language = "English",
volume = "6",
pages = "2178--2187",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species-mediated damage

AU - Oh, Se Yeong

AU - Sohn, Young Woo

AU - Park, Jong Whi

AU - Park, Hyo Jung

AU - Jeon, Hye Min

AU - Kim, Tae Kyung

AU - Lee, Joong Seob

AU - Jung, Ji Eun

AU - Jin, Xun

AU - Chung, Yong Gu

AU - Choi, Young Ki

AU - You, Seungkwon

AU - Lee, Jang Bo

AU - Kim, Hyunggee

PY - 2007/8/1

Y1 - 2007/8/1

N2 - We have established several glioma-relevant oncogene-engineered cancer cells to reevaluate the oncogene-selective cytotoxicity of previously well-characterized anticancer drugs, such as etoposide, doxorubicin, staurosporine, and carmustine. Among several glioma-relevant oncogenes (activated epidermal growth factor receptor, Ras, and Akt, as well as Bcl-2 and p53DD used in the present study), the activated epidermal growth factor receptor, Ras, and Akt exerted oncogenic transformation of Ink4a/Arf -/- murine astrocyte cells. We identified that etoposide, a topoisomerase II inhibitor, caused selective killing of myristylated Akt (Akt-myr)-transduced Ink4a/Arf-/- astrocytes and U87MG cells in a dose- and time-dependent manner. Etoposide-selective cytotoxicity in the Akt-myr-transduced cells was shown to be caused by nonapoptotic cell death and occurred in a p53-independent manner. Etoposide caused severe reactive oxygen species (ROS) accumulation preferentially in the Akt-myr-transduced cells, and elevated ROS rendered these cells highly sensitive to cell death. The etoposide-selective cell death of Akt-myr-transduced cells was attenuated by pepstatin A, a lysosomal protease inhibitor. In the present study, we show that etoposide might possess a novel therapeutic activity for oncogenic Akt-transduced cancer cells to kill preferentially through ROS-mediated damage.

AB - We have established several glioma-relevant oncogene-engineered cancer cells to reevaluate the oncogene-selective cytotoxicity of previously well-characterized anticancer drugs, such as etoposide, doxorubicin, staurosporine, and carmustine. Among several glioma-relevant oncogenes (activated epidermal growth factor receptor, Ras, and Akt, as well as Bcl-2 and p53DD used in the present study), the activated epidermal growth factor receptor, Ras, and Akt exerted oncogenic transformation of Ink4a/Arf -/- murine astrocyte cells. We identified that etoposide, a topoisomerase II inhibitor, caused selective killing of myristylated Akt (Akt-myr)-transduced Ink4a/Arf-/- astrocytes and U87MG cells in a dose- and time-dependent manner. Etoposide-selective cytotoxicity in the Akt-myr-transduced cells was shown to be caused by nonapoptotic cell death and occurred in a p53-independent manner. Etoposide caused severe reactive oxygen species (ROS) accumulation preferentially in the Akt-myr-transduced cells, and elevated ROS rendered these cells highly sensitive to cell death. The etoposide-selective cell death of Akt-myr-transduced cells was attenuated by pepstatin A, a lysosomal protease inhibitor. In the present study, we show that etoposide might possess a novel therapeutic activity for oncogenic Akt-transduced cancer cells to kill preferentially through ROS-mediated damage.

UR - http://www.scopus.com/inward/record.url?scp=34548101114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548101114&partnerID=8YFLogxK

U2 - 10.1158/1535-7163.MCT-07-0111

DO - 10.1158/1535-7163.MCT-07-0111

M3 - Article

VL - 6

SP - 2178

EP - 2187

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 8

ER -